Speaker illustration

Doctor Natalie Arnold

University Heart and Vascular Centre Hamburg (UHZ), Hamburg (Germany)

Can the association between LDL-Cholesterol and incident coronary heart disease (CHD) be modulated by concomitant Lp(a) levels in the general population?

Event: ESC Congress 2023

Topic: Lipids

Session: Modifying lipids to decrease cardiovascular risk

Thumbnail

C-reactive protein as a possible modifier of Lipoprotein(a)-related risk for coronary heart disease in Europe: Results from the BiomarCARE project

Event: ESC Congress 2022

Topic: Biomarkers

Session: Cardiovascular risk assessment - Biomarkers 1

Thumbnail

ESC 365 is supported by

logo Novo Nordisk
logo Bristol Myers Squibb